Core Viewpoint - Thermo Fisher Scientific has issued a profit warning for 2026, citing lower-than-expected annual profits and ongoing pressure from reduced U.S. academic research funding, leading to cautious customer attitudes [1][3]. Financial and Market Context - The company reported revenues of $44.56 billion in 2025, representing a 4% year-over-year increase [5]. - The ongoing reduction in U.S. academic research funding, influenced by previous government policies, has led to more cautious purchasing behavior from research institutions, which are key customers for Thermo Fisher [2][4]. Operational Adjustments - The company plans to gradually close a manufacturing facility in Franklin, Massachusetts, resulting in the layoff of 103 employees, with operations shifting to other U.S. production sites [1][3]. - The closure process is expected to be completed by the end of 2026, with layoffs starting on December 31, 2026, and potentially continuing into 2027 [2][4]. - In early January 2026, the company announced the closure of another manufacturing facility in Asheville, North Carolina, affecting 421 jobs [2][4]. Strategic Initiatives - Despite facing industry headwinds, the company is committed to enhancing its global competitiveness and has pledged to invest an additional $2 billion over the next four years in U.S. manufacturing and R&D [5]. - A new manufacturing facility covering 375,000 square feet was opened in Mebane, North Carolina, as part of this investment strategy [5]. - The company is balancing closures and new investments to maintain competitiveness and lay the groundwork for long-term growth [5].